Levitra Therapy
BERLIN, GERMANY (Press Release) - A Study Evaluating the Efficacy of Treatment in the Levitra Patient and his Female Partner
What is the REPEAT study and its objective?
REPEAT is the first study to seek to gain an insight into not just the experience of men erectile dysfunction (ED) treated with vardenafil (Levitra), but also the feedback and experiences their female partners and physicians. The objective of this international, prospective, observational, non-interventional Post-Marketing Surveillance Study (PMS) study is to evaluate the safety and efficacy of Levitra in routine treatment of ED.
What is the REPEAT study population?
REPEAT study includes 20,000 men aged ~18 years that have ED, as well as their female partners and treating physicians.
What is the REPEAT study design?
REPEAT study was initiated in January 2007 and will continue over the next three years with approximately 20 countries taking part. This study includes a questionnaire for the man, his partner and physician, focusing on their satisfaction with Levitra. The observational period will start with signing of the investigator agreement by the physician. An initial visit will to be carried out before the start of the Levitra therapy. One initial visit and least at one follow-up visit of the patient are necessary. Follow-up visits will be done every three months and the last visit will be documented after 12 month or at the end of the therapy.
What does the REPEAT study hope to achieve?
REPEAT study will help ascertain the levels of communication between the patient, partner and physician regarding their ED and it treatment. It will provide further insight into the treatment seeking habits of the couples and their level of education regarding different treatments including Levitra. The study will also provide information about the prescribing habits of the physician and their knowledge of ED treatments, especially Levitra.
Source: urotoday.com